Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(40%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Completed1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting240%
completed120%
unknown120%
terminated120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF

NCT05510167
completednot_applicable

Vasopressin in Intraabdominal Pressure Elevation

NCT03707054
recruitingnot_applicable

AF Screening in Patients With Abnormal Echocardiographic Parameters

NCT07278089
terminated

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

NCT04397172
unknownnot_applicable

Shortening Treatments Of Chronic Inflammatory Conditions

NCT04848649

Clinical Trials (5)

Showing 5 of 5 trials
NCT05510167Not Applicable

Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF

Recruiting
NCT03707054Not Applicable

Vasopressin in Intraabdominal Pressure Elevation

Completed
NCT07278089Not Applicable

AF Screening in Patients With Abnormal Echocardiographic Parameters

Recruiting
NCT04397172

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

Terminated
NCT04848649Not Applicable

Shortening Treatments Of Chronic Inflammatory Conditions

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5